T-cell large granular lymphocyte leukemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| T-cell large granular lymphocyte leukemia Classification and external resources | |
| ICD-O: | 9831/3 |
|---|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [13] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [14] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
T-cell large granular lymphocyte leukemia is a disease that exhibits a unexplained, chronic (> 6 months) elevation in large granular lymphocytes (LGLs) in the peripheral blood.[1]
It is also known by the following terms: Proliferation of large granular lymphocytes (LGLs), LGL leukemia, Tγ-lymphoproliferative disorder, T-cell chronic lymphocytic leukemia[1]
Epidemiology
T-LGL is a rare form of leukemia, comprising 2-3% of all cases of small lymphocytic leukemias.[1]
Clinical Features
Etiology
The postulated cells of origin are a transformed CD8+ T-cell with clonal rearrangements of β chain T-cell receptor genes for the majority of cases and a CD8- T-cell with clonal rearrangements of γ chain T-cell receptor genes for a minority of cases.[1]
Clinical Presentation
This disease is known for an indolent clinical course and incidental discovery.[1] The most common physical finding is moderate splenomegaly. B symptoms are seen in a third of cases, and recurrent infections due to the associated neutropenia are seen in almost half of cases.[2][3][4][5] Rheumatoid arthritis is commonly observed in patients with T-LGL, leading to a clinical presentation similar to Felty's syndrome.[6] Signs and symptoms of anemia are commonly found, due to the association between T-LGL and erythroid hypoplasia.[7]
Laboratory Findings
The requisite lymphocytosis of this disease is typically 2-20x109/L.[7] Immunoglobulin derangements including hypergammaglobulinemia, autoantibodies, and circulating immune complexes are commonly seen.[8][9][10][5]
Sites of Involvement
The leukemic cells of T-LGL can be found in peripheral blood, bone marrow, spleen, and liver. Nodal involvement is rare.[1][2]
Morphology
Peripheral blood
The neoplastic lymphocytes seen in this disease are large in size with azurophilic granules that contains proteins involved in cell lysis such as perforin and granzyme B.[11]
Bone marrow
Bone marrow involvement in this disease is often present, but to a variable extent. The lymphocytic infiltrate is usually interstitial, but a nodular pattern rarely occurs.[1]
Molecular Findings
Immunophenotype
The neoplastic cells of this disease display a mature T-cell immunophenotype, with the majority of cases showing a CD4-/CD8+ T-cell subset immunophenotype versus other permutations of those markers.[3][4] Variable expression of CD11b, CD56, and CD57[5] are observed. Immunohistochemisty for perforin, TIA-1, and granzyme B are usually positive.[1]
| Type | Immunophenotype |
|---|---|
| Common type (80% of cases) | CD3+, TCRαβ+, CD4-, CD8+ |
| Rare variants | CD3+, TCRαβ+, CD4+, CD8- |
| CD3+, TCRαβ+, CD4+, CD8+ | |
| CD3+, TCRγδ+, CD4 and CD8 variable |
Genetic Findings
Clonal rearrangements of the T-cell receptor (TCR) genes are a necessary condition for the diagnosis of this disease. The gene for the β chain of the TCR is found to be rearranged more often than the γ chain. of the TCR.[9][12]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 [1] Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon 2001
- ↑ 2.0 2.1 [2] Lamy T, Loughran TP. "Large Granular Lymphocyte Leukemia." Cancer Control. 1998 Jan;5(1):25-33. PMID: 10761014
- ↑ 3.0 3.1 [3] Chan WC, Link S, Mawle A, Check I, Brynes RK, Winton EF. "Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes." Blood. 1986 Nov;68(5):1142-53. PMID: 3490288
- ↑ 4.0 4.1 [4] Pandolfi F, Loughran TP Jr, Starkebaum G, Chisesi T, Barbui T, Chan WC, Brouet JC, De Rossi G, McKenna RW, Salsano F, et al. "Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study." Cancer. 1990 Jan 15;65(2):341-8. PMID: 2403836
- ↑ 5.0 5.1 5.2 [5] Lamy T, Loughran TP Jr. "Clinical features of large granular lymphocyte leukemia." Semin Hematol. 2003 Jul;40(3):185-95. PMID: 12876667
- ↑ [6] Loughran TP Jr, Starkebaum G, Kidd P, Neiman P. "Clonal proliferation of large granular lymphocytes in rheumatoid arthritis." Arthritis Rheum. 1988 Jan;31(1):31-6. PMID: 3345230
- ↑ 7.0 7.1 [7] Kwong YL, Wong KF. "Association of pure red cell aplasia with T large granular lymphocyte leukaemia." J Clin Pathol. 1998 Sep;51(9):672-5. PMID: 9930071
- ↑ [8] Oshimi K, Yamada O, Kaneko T, Nishinarita S, Iizuka Y, Urabe A, Inamori T, Asano S, Takahashi S, Hattori M, et al. "Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders." Leukemia. 1993 Jun;7(6):782-8. PMID: 8388971
- ↑ 9.0 9.1 [9] Loughran TP Jr, Starkebaum G, Aprile JA. "Rearrangement and expression of T-cell receptor genes in large granular lymphocyte leukemia." Blood. 1988 Mar;71(3):822-4. PMID: 3345349
- ↑ [10] Loughran TP Jr, Kadin ME, Starkebaum G, Abkowitz JL, Clark EA, Disteche C, Lum LG, Slichter SJ. "Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia." Ann Intern Med. 1985 Feb;102(2):169-75. PMID: 3966754
- ↑ [11] Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. "The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis." Blood. 1997 Jan 1;89(1):256-60. PMID: 8978299
- ↑ [12] Vie H, Chevalier S, Garand R, Moisan JP, Praloran V, Devilder MC, Moreau JF, Soulillou JP. "Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder." Blood. 1989 Jul;74(1):285-90. PMID: 2546620
WikiDoc Research Resources for T-cell large granular lymphocyte leukemia | |
|---|---|
| Articles on T-cell large granular lymphocyte leukemia | Most recent articles on T-cell large granular lymphocyte leukemia • Most cited articles on T-cell large granular lymphocyte leukemia • Review articles on T-cell large granular lymphocyte leukemia • Articles on T-cell large granular lymphocyte leukemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on T-cell large granular lymphocyte leukemia | Powerpoint slides on T-cell large granular lymphocyte leukemia • Images of T-cell large granular lymphocyte leukemia • Photos of T-cell large granular lymphocyte leukemia • Podcasts & MP3s on T-cell large granular lymphocyte leukemia • Videos on T-cell large granular lymphocyte leukemia |
| Evidence Based Medicine Regarding T-cell large granular lymphocyte leukemia | Cochrane Collaboration on T-cell large granular lymphocyte leukemia • Bandolier on T-cell large granular lymphocyte leukemia • TRIP on T-cell large granular lymphocyte leukemia |
| Cost Effectiveness of T-cell large granular lymphocyte leukemia | Cost Effectiveness of T-cell large granular lymphocyte leukemia |
| Clinical Trials Involving T-cell large granular lymphocyte leukemia | Ongoing Trials on T-cell large granular lymphocyte leukemia at Clinical Trials.gov • Trial results on T-cell large granular lymphocyte leukemia • Clinical Trials on T-cell large granular lymphocyte leukemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding T-cell large granular lymphocyte leukemia | US National Guidelines Clearinghouse on T-cell large granular lymphocyte leukemia • NICE Guidance on T-cell large granular lymphocyte leukemia • NHS PRODIGY Guidance • FDA on T-cell large granular lymphocyte leukemia • CDC on T-cell large granular lymphocyte leukemia |
| Textbook Information on T-cell large granular lymphocyte leukemia | Books and Textbook Information on T-cell large granular lymphocyte leukemia |
| Pharmacology Resources on T-cell large granular lymphocyte leukemia | Dosing of T-cell large granular lymphocyte leukemia • Drug interactions with T-cell large granular lymphocyte leukemia • Side effects of T-cell large granular lymphocyte leukemia • Allergic reactions to T-cell large granular lymphocyte leukemia • Overdose information on T-cell large granular lymphocyte leukemia • Carcinogenicity information on T-cell large granular lymphocyte leukemia • T-cell large granular lymphocyte leukemia in pregnancy • Pharmacokinetics of T-cell large granular lymphocyte leukemia • |
| Genetics, Pharmacogenomics, and Proteinomics of T-cell large granular lymphocyte leukemia | Genetics of T-cell large granular lymphocyte leukemia • Pharmacogenomics of T-cell large granular lymphocyte leukemia • Proteomics of T-cell large granular lymphocyte leukemia |
| Newstories on T-cell large granular lymphocyte leukemia | T-cell large granular lymphocyte leukemia in the news • Be alerted to news on T-cell large granular lymphocyte leukemia • News trends on T-cell large granular lymphocyte leukemia |
| Commentary on T-cell large granular lymphocyte leukemia | Blogs on T-cell large granular lymphocyte leukemia |
| Patient Resources on T-cell large granular lymphocyte leukemia | Patient resources on T-cell large granular lymphocyte leukemia • Discussion groups on T-cell large granular lymphocyte leukemia • Patient Handouts on T-cell large granular lymphocyte leukemia • Directions to Hospitals Treating T-cell large granular lymphocyte leukemia • Risk calculators and risk factors for T-cell large granular lymphocyte leukemia |
| Healthcare Provider Resources on T-cell large granular lymphocyte leukemia | Symptoms of T-cell large granular lymphocyte leukemia • Causes & Risk Factors for T-cell large granular lymphocyte leukemia • Diagnostic studies for T-cell large granular lymphocyte leukemia • Treatment of T-cell large granular lymphocyte leukemia |
| Continuing Medical Education (CME) Programs on T-cell large granular lymphocyte leukemia | CME Programs on T-cell large granular lymphocyte leukemia |
| International Resources on T-cell large granular lymphocyte leukemia | T-cell large granular lymphocyte leukemia en Espanol • T-cell large granular lymphocyte leukemia en Francais |
| Business Resources on T-cell large granular lymphocyte leukemia | T-cell large granular lymphocyte leukemia in the Marketplace • Patents on T-cell large granular lymphocyte leukemia |
| Informatics Resources on T-cell large granular lymphocyte leukemia | List of terms related to T-cell large granular lymphocyte leukemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
